Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #156176 on Rivulet Media Inc (fka RIVU)
ADVFN_franknstein
01/09/17 9:48 AM
#156178 RE: gotinearly #156176
Regen As of December 13, 2016 Bio-Matrix Scientific Group, Inc owns 29,076,665 Common Shares of Regen, 2,907,666 shares of Regen’s Series A Preferred Stock, 30,000 shares of Regen’s Series AA Preferred Stock representing 11.1% of our outstanding share capital and 56.65% of the voting power as of December 13, 2016.
Entest As of November 15, 2016 Bio-Matrix Scientific Group Inc. owned 66,667 common shares of the Company . As of November 15, 2016 Regen Biopharma owns 8,000,000 common shares of the Company Entest Biomedical Inc. is under common control with Bio Matrix Scientific Group.